Why are some drugs considered socially acceptable while others are demonized? What makes these definitions so widespread? Who benefits from these conceptualizations? The Drug Paradox examines both the empirically founded and the socially constructed facets of drugs and drug use, highlighting the incongruous aspects of laws, policies, and programming that aim to address behaviours around drugs. The authors explore this paradox, arguing that Canada’s punitive approach to addressing drug use continues to exist alongside harm-reduction strategies and that these competing approaches ultimately impede Canada’s ability to deal effectively with substance misuse. Using a policy-oriented approach while also emphasizing the utility of a multifaceted biopsychosocial model, this text provides students with a foundation in the sociology of psychoactive substances in the Canadian context. It covers a broad range of issues—models of addiction, the history of Canada’s drug laws, media representation, government responses to substance use, and international perspectives on drug policy—and addresses various research areas that are important for students to consider when trying to make sense of the competing discourses on drugs in society. The Drug Paradox is ideal for use in sociology courses on drugs and drug use and will also appeal to those focusing on drug use from a criminology, public health, or policy perspective.

Canada has become the first G7 country to legalize cannabis, and the world is watching. The primary concern facing the Liberal government as it seeks to fulfill its 2015 campaign promise to “legalize, regulate, and restrict access to marijuana” is whether it can be done without making the situation worse. As the Liberal platform pointed out, the current regime lets illegal cannabis fall into the hands of minors, pours large profits into organized crime, and traps many people in the criminal justice system for what is arguably a victimless crime. While the legalization of marijuana in Canada begins with a straightforward change of the criminal code, its ramifications go far beyond this. Legalization will have a serious impact on the country's international treaty commitments, interprovincial relations, taxation and regulatory regimes, and social and health policies. The essays in this book address these outcomes from three main perspectives: the decades-long political path to legalization; the assumptions that underwrite the new policy, in particular the desire to stamp out the black market; and how legalization in Canada looks in an international context. Bringing together analysis by policy makers and scholars, including the architect of marijuana legislation in Portugal – a trailblazing jurisdiction – High Time provides an urgent and necessary overview of Canada's Cannabis Act.

In this book the author, an investigative journalist, traces the social history of marijuana from its origins to its emergence in the 1960s as a defining force in an ongoing culture war. He describes how the illicit marijuana subculture overcame government opposition and morphed into a multibillion-dollar industry. In 1996, Californians voted to legalize marijuana for medicinal purposes. Similar laws have followed in several other states, but not without antagonistic responses from federal, state, and local law enforcement. The author draws attention to underreported scientific breakthroughs that are reshaping the therapeutic landscape: medical researchers have developed promising treatments for cancer, heart disease, Alzheimer's, diabetes, chronic pain, and many other conditions that are beyond the reach of conventional cures. This book is an examination of the medical, recreational, scientific, and economic dimensions of the world's most controversial plant.

Vols. for 1963- include as pt. 2 of the Jan. issue: Medical subject headings.

Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€"outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€"that summarizes and prioritizes pressing research needs.

One of those rare, unforgettable novels that are as chilling as they are insightful, as thought-provoking as they are terrifying, award-winning author Connie Willis's Passage is an astonishing blend of relentless suspense and cutting-edge science unlike anything you've ever read before. It is the electrifying story of a psychologist who has devoted her life to tracking death. But when she volunteers for a research project that simulates the near-death experience, she will either solve life's greatest mystery -- or fall victim to its greatest terror. At Mercy General Hospital, Dr. Joanna Lander will soon be paged -- not to save a life, but to interview a patient just back from the dead. A psychologist specializing in near-death experiences, Joanna has spent two years recording the experiences of those who have been declared clinically dead and lived to tell about it. It's research on the fringes of ordinary science, but Joanna is about to get a boost from an unexpected quarter. A new doctor has arrived at Mercy General, one with the power to give Joanna the chance to get as close to death as anyone can. A brilliant young neurologist, Dr. Richard Wright has come up with a way to manufacture the near-death experience using a psychoactive drug. Dr. Wright is convinced that the NDE is a survival mechanism and that if only doctors understood how it worked, they could someday delay the dying process, or maybe even reverse it. He can use the expertise of a psychologist of Joanna Lander's standing to lend credibility to his study. But he soon needs Joanna for more than just her reputation. When his key volunteer suddenly drops out of the study, Joanna finds herself offering to become Richard's next subject. After all, who better than she, a trained psychologist, to document the experience? Her first NDE is as fascinating as she imagined it would be -- so astounding that she knows she must go back, if only to find out why this place is so hauntingly familiar. But each time Joanna goes under, her sense of dread begins to grow, because part of her already knows why the experience is so familiar, and why she has every reason to be afraid.... And just when you think you know where she is going, Willis throws in the biggest surprise of all -- a shattering scenario that will keep you feverishly reading until the final climactic page is turned.

In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it. It presents the first comprehensive overview of the international regulation, policy and market structure of the NPS phenomenon, offering a guide to inform legislative discussions and demonstrating from a comparative perspective the different approaches used to address the rise of NPS to date. It covers topics such as organized crime, drug markets, clinical evidence on NPS, and different regulatory approaches also in less explored settings such as prisons and sport environments. Overall, this highly informative and well-structured repository of different experiences with NPS policy, law and regulation offers an essential primary source of evidence for anyone interested in the area of drug and NPS policy, health economics and p ublic health.

Now on Netflix as a 4-part documentary series! “Pollan keeps you turning the pages . . . cleareyed and assured.” —New York Times A #1 New York Times Bestseller, New York Times Book Review 10 Best Books of 2018, and New York Times Notable Book A brilliant and brave investigation into the medical and scientific revolution taking place around psychedelic drugs--and the spellbinding story of his own life-changing psychedelic experiences When Michael Pollan set out to research how LSD and psilocybin (the active ingredient in magic mushrooms) are being used to provide relief to people suffering from difficult-to-treat conditions such as depression, addiction and anxiety, he did not intend to write what is undoubtedly his most personal book. But upon discovering how these remarkable substances are improving the lives not only of the mentally ill but also of healthy people coming to grips with the challenges of everyday life, he decided to explore the landscape of the mind in the first person as well as the third. Thus began a singular adventure into various altered states of consciousness, along with a dive deep into both the latest brain science and the thriving underground community of psychedelic therapists. Pollan sifts the historical record to separate the truth about these mysterious drugs from the myths that have surrounded them since the 1960s, when a handful of psychedelic evangelists inadvertently catalyzed a powerful backlash against what was then a promising field of research. A unique and elegant blend of science, memoir, travel writing, history, and medicine, How to Change Your Mind is a triumph of participatory journalism. By turns dazzling and edifying, it is the gripping account of a journey to an exciting and unexpected new frontier in our understanding of the mind, the self, and our place in the world. The true subject of Pollan's "mental travelogue" is not just psychedelic drugs but also the eternal puzzle of human consciousness and how, in a world that offers us both suffering and joy, we can do our best to be fully present and find meaning in our lives.